Nephros Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,698.00
7,371.00
3,088.00
3,032.00
809.00
3,325
Depreciation, Depletion & Amortization
223.00
216.00
212.00
230.00
218.00
163
Other Funds
1,118.00
5,037.00
227.00
708.00
907.00
1,352
Funds from Operations
2,357.00
2,118.00
2,649.00
2,094.00
316.00
1,810
Changes in Working Capital
1,226.00
377.00
1,166.00
18.00
393.00
1,852
Net Operating Cash Flow
3,583.00
2,495.00
3,815.00
2,112.00
77.00
3,662
Capital Expenditures
-
-
13.00
45.00
-
Sale of Fixed Assets & Businesses
3.00
-
-
-
-
Net Investing Cash Flow
3.00
-
13.00
45.00
-
Issuance/Reduction of Debt, Net
1,101.00
1,678.00
-
1,187.00
711.00
Net Financing Cash Flow
4,120.00
3,203.00
3,791.00
1,188.00
1,990.00
Net Change in Cash
532.00
705.00
36.00
973.00
1,919.00
Free Cash Flow
3,583.00
2,495.00
3,828.00
2,157.00
77.00
Change in Capital Stock
3,019.00
4,881.00
3,791.00
1.00
1,279.00
Exchange Rate Effect
8.00
3.00
1.00
4.00
6.00

About Nephros

View Profile
Address
380 Lackawanna Place
South Orange New Jersey 07079
United States
Employees -
Website http://www.nephros.com
Updated 07/08/2019
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentratae and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.